Amifostine-based nanoemulsio as promising protective agent for nephrotoxicity
DOI:
https://doi.org/10.56511/JIPBS.2018.v5.i04.pp38-45Abstract
Drug-induced kidney injury is the causative of acute kidney failure. Amifostine loaded Silica nanoemulsion was synthesized using water/oil emulsion with the help of ultra-sonication waves. The nanoemulsion was prepared using tetraethyl orthosilicate [TEOS], cetyltrimethyl ammonium bromide [CTAB], castor oil [CAO] and amifostine [AMF] as a source for silica, surfactant, extra stabilizing agent and a model drug respectively. The as synthesized nanoemulsion of silica and silica loaded with amifostine [SiNPs@AMF] was examined via transmission electron microscopy [TEM] and dynamic light scattering [DLS] in terms of particles shape and hydrodynamic average size. The work was extended to achieve the target of the current work target to investigate the protective role of this nanoemulsion model as cytoprotector drug effect against cisplatin-induced nephrotoxicity in male albino rats. It was clearly seen that the successful preparation of the as-synthesized silica nanoemulsion loaded with amifostine [SiNPs@AMF] but the particle size was marginally increased when comparing with silica nanoemulsion. Additionally, blood urea and serum creatinine were increased after cisplatin injection with disorders in oxidative stress and rising of serum KIM-1 and urinary 8-hydroxyguanosine levels. Also, histopathological changes of the kidney tissue were observed. These changes back to normal by treatment with silica nanoparticles loaded amifostine [SiNPs@AMF]. Oil/water nanoemulsion of [SiNPs@AMF] showed a protective and promising preventive strategy against nephrotoxicity due to their cytoprotective and antioxidant effects.
Keywords:
Drug nephrotoxicity, Silica nanoparticles, Amifostine, CisplatinDownloads
References
Liebler DC and Guengerich FP. Elucidating mechanisms of drug-induced toxicity. Nat. Rev. Drug Discov. 2005; 4:410 – 420 .
Fisel P, Renner O, Nies AT, et al. Solute carrier transporter and drugrelated nephrotoxicity. the impact of proximal tubule cell models for preclinical research. Expert Opin Drug Metab Toxicol. 2014; 10:395 – 408.
Tiong HY. Drug-Induced Nephrotoxicity. Clinical Impact and Preclinical in Vitro Models. Mol Pharm. 2014; 11: 1933 – 1948.
Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician 2008; 78: 743 – 750.
Qing M, Shiva RD. et al. Amelioration of cisplatin-induced acute kidney injury by recombinant neutrophil gelatinase-associated lipocalin. Renal Failure 2016; 38(9): 1476 – 1482.
Karasawa T and Steyger PS. An integrated view of cisplatin induced Nephrotoxicity and ototoxicity. Toxicol Lett. 2015; 237: 219 – 227.
Kawai Y , Taniuchi S , et al. Relationship between cisplatin or nedaplatininduced nephrotoxicity and renal accumulation. Biol Pharm Bull. 2005; 28(8):1385-8.
Arany I and Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol. 2003; 5:460 – 464.
Melis M, Valkema R, Krenning EP, Dejong M. Reduction of renal uptake of radiolabelled octreotate by amifostine administration. J.Nucl. Med. 2012; 53(5):749-753.
Balla A, Toth B, Timar G, Bak J, Krajcsi P. Molecular targets for pharmacological cytoprotection. Biochem. Pharmacol. 2001; 61(7):769777.
Yang X, Yanping Ding, Tianjiao Ji, Xiao Zhao, et al. Improvement of the in vitro safety profile and cytoprotective efficacy of amifostine against chemotherapy by PEGylation strategy. Biochemical Pharmacology. 2016; 108(15): 11 – 21.
Sarawoot P, Chuchard P, Dtsadee C and Prasit S. Amelioration of Cisplatin-Induced Nephrotoxicity in Rats by Curcumin and α -Tocopherol. Tropical Journal of Pharmaceutical Research 2013; 12 (6): 973-979.
Manna F, Ahmed HH, Estefan SF, Sharaf HA and Eskander E.F. Saccharomyces cerevisiae intervension for relieving flutamide-induced hepatotoxicity in male rats. Pharmazie. 2005; 60: 689-695.
Young DS. Effect of drugs on clinical laboratory tests. 5th Ed. 2005; AACC press, Washington D.C.
Young DS. Effect of preanalytical variables on Clinical Laboratory Tests, 3rd. 2007; Washington D.C
Ruiz-Larrea MB, Leal AM et al. Antioxidant effects of estradiol and 2hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 1994; 59:383 – 388.
Moshage H, Kok B. et al. Nitrite and nitrate determination in plasma: a critical evaluation. Clin Chem. 1995; 41:892 – 896.
Patil SP, Jain PD, et al. Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice. Neuropharmacology 2014; 86:192-202.
Kim M, Moon H, Hong S. Determination of urinary 8-hydroxy-2deoxy guanosine as a DNA damage marker. Am. Clin. Lab 2001; 42-45.
Larsen K. Creatinine assay by a reaction-kinetic principle. Clin. Chim. Acta 1972; 41:209-217.
El-Khayat Z., Rasheed W., Ramzy T., Hussein J., Agaiby M., Morsy S., Morsy F., Shaffie N. Protective effect of garlic oil against liver injury in experimental animals, J. Med. Plants Res. 20104; (22):2359-2369.
Xiupu Shi, Sha Liao, et al. Hesperid in Prevents Retinal and Plasma Abnormalities in Streptozotocin-Induced Diabetic Rats. Molecules 2012; 17: 12868-12881 .
Autrup H, Barile FA, et al. Principles of Pharmacology and Toxicology Also Govern Effects of Chemicals on the Endocrine System. Toxicol Sci. 2015; 146 (1):11-5 .
Brizel DM. Future directions in toxicity prevention. Semin. Radiat. Oncol. 1998; 8: 17.
Grdina DJ, KataokaY., Murley JS. Amifostine mechanisms of action underlying cytoprotection and chemoprevention. Drug Metab. Drug Interact. 2000; 16: 237.
Stankiewicz A and Skrzydlewska E. Amifostine antioxidant effect on serum of rats treated with cyclophosphodamide. Polish Journal of Enviromental Studies 2005; 14(3): 341-346.
Qi L , Shouyu H , et al. The protective effects of Zhen-Wu-Tang against cisplatin-induced acute kidney injury in rats. PLoS One . 2017; 12(6): 129137.
Muriach M, Flores-Bellver M, et al. Diabetes and the brain: Oxidative stress, inflammation, and autophagy. Oxidative Medicine and Cellular Longevity Volume 2014, Article ID 102158, 9 pages.
Moreira PI, Cardoso S M, et al. Mitochondria as a therapeutic target in Alzheimer’s disease and diabetes. CNS & Neurological Di sorders-Drug Targets [Formerly Current Drug Targets-CNS & Neurological Disorders] 2009; 8(6): 492 – 511.
Jafari AI, Sankian M, et al. Evaluation of Bcl-2 family gene expression and Caspase-3 activity in hippocampus STZ-induced diabetic rats. Experimental Diabetes Research Volume 2008, Article ID 638467, 6 pages.
Stepniak J, Karbownik-Lewinska M. 17 β -estradiol prevents experimentally oxidative damage to membrane lipids and nuclear DNA in porcine ovary. Syst Biol Reprod Med. 2016; 62:17-21.
Cadet J. Oxidative degradation pathways of cellular DNA: product formation and mechanistic insights. Free Radical Biology and Medicine. 2014; 75:p. S2. doi: 10.1016/j.freeradbiomed.2014.10.598.
Altuner D., Gulaboglu M., Yapca O. E., Cetin N. The effect of mirtazapine on cisplatin-induced oxidative damage and infertility in rat ovaries. The Scientific World Journal. 2013. Volume 2013, Article ID 327240, 6 pages.
Stankiewicz A., Skrzydlewska E. Protection against cyclophosphamideinduced renal oxidative stress by amifostine: the role of antioxidative mechanisms. Toxicol. Mech. Methods. 2003; 13: 1.
Takaharu Ichimura, Cheng Chieh Hung, Soon Ae Yang, James L. Stevens, and Joseph V. Bonventre. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.2004; Am J Physiol Renal Physiol 286: F552 – F563.
Published
How to Cite
Issue
Section
Copyright (c) 2018 Nadia A. Mohamed, Mehrez E. El-Naggar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at